What is the equity of Organo this year?
Organo has equity of 101.93 B JPY this year.
Organo Equity 2024
Organo Equity
101.93 B JPY
Ticker
6368.T
ISIN
JP3201600008
In 2024, Organo's equity was 101.93 B JPY, a 34.41% increase from the 75.84 B JPY equity in the previous year.
Organo Aktienanalyse
What does Organo do?
Organo Corp is an internationally operating company specialized in the production and distribution of products in the health and wellness industry. The company was founded in Vancouver, Canada in 2008 by Bernardo Chua. Organo Corp's business model is based on network marketing to sell its products. This has allowed the company to quickly build a large customer base and become active in over 50 countries. The goal of Organo Corp is to help every customer lead a healthier and happier life. Organo Corp is divided into different divisions to offer customers a wide range of products. One of the main divisions is "Organo Gold," which offers coffee and tea products. These products are based on traditional Asian herbs and fungi such as Reishi, Ganoderma, and Cordyceps. These herbs have many active ingredients that strengthen the immune system, increase energy levels, reduce stress, and promote overall well-being. Another division of Organo Corp is "Organo Essentials," which offers products for a healthy everyday life. This includes supplements such as multivitamin tablets, protein powder, and Omega-3 fatty acids. These supplements are made from high-quality ingredients and aim to improve overall well-being. Organo Corp also has a "Personal Care" division, which offers products for personal hygiene. These include soaps, shampoos, creams, and lotions. These products contain natural ingredients such as tea tree oil, aloe vera, shea butter, and various essential oils that are intended to nourish and protect the skin. The company also has an "Organo Graphics" division, which offers marketing materials to help independent distributors of Organo Corp build their own business. This includes brochures, business cards, and sales tools. Organo Corp has also made a name for itself through various philanthropic activities. The company has established the "OG Care Foundation," which advocates for disadvantaged children and their families worldwide. The foundation supports projects in the areas of education, health, and well-being. In summary, Organo Corp is a company specializing in the sale of products in the health and wellness industry. The company offers a wide range of products based on natural ingredients such as Asian herbs and fungi. Through network marketing, Organo Corp has quickly built a large customer base and is now active in over 50 countries. Additionally, the company is committed to supporting disadvantaged children around the world through the "OG Care Foundation." Organo ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Organo's Equity
Organo's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Organo's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Organo's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Organo's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Organo’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Organo stock
What was the equity of Organo compared to the previous year?
The equity of Organo has increased/decreased by 34.41% increased compared to the previous year.
What impact does a high equity have on investors of Organo?
A high equity is advantageous for investors of Organo as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Organo?
A low equity can be a risk for investors of Organo, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Organo affect the company?
An increase in equity of Organo can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Organo affect the company?
A reduction in equity of Organo can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Organo?
Some factors that can affect the equity of Organo include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Organo so important for investors?
The equity of Organo is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Organo take to change the equity?
To change equity, Organo can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Organo pay?
Over the past 12 months, Organo paid a dividend of 114 JPY . This corresponds to a dividend yield of about 1.85 %. For the coming 12 months, Organo is expected to pay a dividend of 118.51 JPY.
What is the dividend yield of Organo?
The current dividend yield of Organo is 1.85 %.
When does Organo pay dividends?
Organo pays a quarterly dividend. This is distributed in the months of October, April, October, April.
How secure is the dividend of Organo?
Organo paid dividends every year for the past 23 years.
What is the dividend of Organo?
For the upcoming 12 months, dividends amounting to 118.51 JPY are expected. This corresponds to a dividend yield of 1.92 %.
In which sector is Organo located?
Organo is assigned to the 'Industry' sector.
Wann musste ich die Aktien von Organo kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Organo from 12/1/2024 amounting to 53 JPY, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.
When did Organo pay the last dividend?
The last dividend was paid out on 12/1/2024.
What was the dividend of Organo in the year 2023?
In the year 2023, Organo distributed 74 JPY as dividends.
In which currency does Organo pay out the dividend?
The dividends of Organo are distributed in JPY.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Organo
Our stock analysis for Organo Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Organo Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
